Back to results
US 2019/0055229 A1Published application
Heteroaryl Substituted Pyridines and Methods of Use
AssigneesAbbVie S.á.r.l., Galapagos NV
InventorsRobert J. Altenbach, Andrew Bogdan, Ghjuvanni Petru Diunisu Coti, Marlon D. Cowart, Stephen N. Greszler, Hans Kelgtermans, Philip R. Kym, Steven Emiel Van der Plas, Xueqing Wang
Life of this patent
Estimating the term…
Abstract
The invention discloses compounds of Formula I, wherein X1, X2, R1, and R2 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.
Claims12
A compound, which is
- wherein one or more hydrogen atoms are replaced by deuterium;
- or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.